# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Needham analyst Gil Blum reiterates Geron (NASDAQ:GERN) with a Buy and maintains $6 price target.
Geron (NASDAQ:GERN) reported quarterly losses of $(0.10) per share which met the analyst consensus estimate. The company repor...
Needham analyst Gil Blum reiterates Geron (NASDAQ:GERN) with a Buy and maintains $6 price target.
Barclays analyst Carter Gould initiates coverage on Geron (NASDAQ:GERN) with a Overweight rating and announces Price Target ...